Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity
| | | | | | | | | |

Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity

On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….

Superbugs could jeopardise food security for over two billion people and increase annual health care costs by U.S. $159 billion annually by 2050, finds most extensive modelling to date 
| | | |

Superbugs could jeopardise food security for over two billion people and increase annual health care costs by U.S. $159 billion annually by 2050, finds most extensive modelling to date 

On Sept. 25, 2024, drug-resistant pathogens could jeopardise the food supply of over two billion people and increase…

Japan’s MHLW Approved CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
| | | |

Japan’s MHLW Approved CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma

On Sept. 13, 2024, CSL Seqirus and sa-mRNA pioneer Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor…